Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-03-15 5:17 pm Purchase | 13G | FOLEY TRASIMENE ACQUISITION CO WPF | MFN Partners Management LP | 5,000,000 4.83% | 5,000,000 (New Position) | View |
| 2021-02-12 5:09 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | MFN Partners Management LP | 2,427,677 7.15% | 939,803 (+63.16%) | View |
| 2021-02-12 5:03 pm Sale | 13G | FOLEY TRASIMENE AQ CORP II UNT BFTU | MFN Partners Management LP | 0 0% | -10,000,000 (Position Closed) | View |
| 2021-02-12 4:59 pm Purchase | 13G | FOLEY TRASIMENE ACQ UNIT 1 COM WPFU | MFN Partners Management LP | 14,000,000 13.53% | 2,000,000 (+16.67%) | View |
| 2020-08-27 4:21 pm Purchase | 13G | FOLEY TRASIMENE AQ CORP II UNT BFTU | MFN Partners Management LP | 10,000,000 7.7% | 10,000,000 (New Position) | View |
| 2020-07-22 3:04 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | MFN Partners Management LP | 1,895,677 4.53% | -2,104,323 (-52.61%) | View |
| 2020-07-10 12:12 pm Purchase | 13G | FOLEY TRASIMENE ACQ UNIT 1 COM WPFU | MFN Partners Management LP | 12,000,000 11.59% | 2,000,000 (+20.00%) | View |
| 2020-06-05 5:18 pm Purchase | 13G | FOLEY TRASIMENE ACQ UNIT 1 COM WPFU | MFN Partners Management LP | 10,000,000 9.67% | 10,000,000 (New Position) | View |
| 2020-02-13 5:07 pm Sale | 13G | CYCLERION THERAPEUTICS INC CYCN | MFN Partners Management LP | 1,487,874 5.4% | -18,978 (-1.26%) | View |
| 2020-02-13 4:53 pm Unchanged | 13G | ACLARIS THERAPEUTICS INC ACRS | MFN Partners Management LP | 4,000,000 9.7% | 0 (Unchanged) | View |
| 2019-10-31 5:26 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | MFN Partners Management LP | 4,000,000 9.7% | 4,000,000 (New Position) | View |